# clm_EDF03CE5BDB7

subject: Vertex Pharmaceuticals (/record/vertex-pharmaceuticals.md)  
predicate: operating_income  
value: 3,832,000,000 United States dollar  
valid_from: 2023-12-31  
valid_to: 2024-12-31  
published: 2024-02-15  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_33A4466539E6  
last_updated: 2026-11-08  
cite: AsOf. "Vertex Pharmaceuticals operating income: 3,832,000,000 United States dollar", as of 2023-12-31 (until 2024-12-31). Claim clm_EDF03CE5BDB7, https://asof.is/claim/clm_EDF03CE5BDB7, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/875320/000087532024000062/0000875320-24-000062-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:OperatingIncomeLoss in 10-K FY2023, filed 2024-02-15  

## Sources

- https://www.sec.gov/Archives/edgar/data/875320/000087532024000062/0000875320-24-000062-index.htm (primary, SEC EDGAR 10-K FY2023, published 2024-02-15)

## Supersedes

- [Vertex Pharmaceuticals](/record/vertex-pharmaceuticals.md) | operating_income | 4,307,400,000 United States dollar | valid 2022-12-31 to 2023-12-31 | conf 0.95 | superseded | superseded_by [clm_EDF03CE5BDB7](/claim/clm_EDF03CE5BDB7.md) | [clm_EA4DD24E67F5](/claim/clm_EA4DD24E67F5.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.